A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LIA / luminometric immunoassay

[Related PubMed/MEDLINE]
Total Number of Papers: 14
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LIA  (>> Co-occurring Abbreviation)
Long Form:   luminometric immunoassay
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death. ACS, MACE, OR, Se, SELENBP1
2002 TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer. ---
2001 The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. BCCS, IHC, OS, RFS, VEGF
2001 Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer. ELISA, FIGO, PAI-1, PFS, PgR, uPA
1999 Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. HCC
1999 Expression of high p53 levels in colorectal cancer: a favourable prognostic factor. CEA
1999 p53 determination in gynecological carcinomas: immunohistochemistry compared to luminometric immunoassay (LIA). IH
1998 Coexpression of p53 and tissue transglutaminase genes in human normal and pathologic adrenal tissues. mRNA, tTG
1998 Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors. IHC
10  1998 P53 accumulation in primary breast cancer: a comparison between immunohistochemistry and a novel luminometric immunoassay. IHC
11  1997 Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols. ---
12  1996 Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis. SSCP
13  1996 Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay. PgR, SPF, uPA
14  1995 Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. ---